HIV/AIDS: WHO issues guidelines on PrEP

HIV/AIDS: WHO issues guidelines on PrEP

Nairobi : Kenya | Jul 20, 2012 at 8:46 AM PDT
Source: IRIN
Views: Pending
Moving forward The guidance comes days after the United States Food and Drug Administration ( FDA ) announced its approval of Truvada for PrEP. The FDA recommended that HIV-negative individuals at high risk should take Truvada daily to lower their chances of becoming infected if they are exposed to... FULL ARTICLE AT IRIN
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
  • Credibility
  • Wait... Flag

News Stories

  • WHO endorses use of HIV medicines for prevention

      Leader Post Online
    Antiretroviral pills Truvada sit on a pharmacy tray in a file photo. The United Nations agency made its suggestion after U.S. regulators approved use of Gilead Sciences Inc's Truvada for people who are not infected but may engage in sexual activity...

More From Allvoices

Most Commented Reports

Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.